記事ID ： 36500

誘導、毒性、薬物代謝などのアッセイにヒト肝臓細胞（Hepatic cells）

カテゴリから探す > 細胞培養／細胞工学 > 幹細胞試料・フィーダー細胞 > 各種幹細胞（間葉系幹細胞など）

メーカー名：Zen-Bio, Inc.

Zen-Bio社では、さまざまなヒト肝臓由来細胞を提供しております。本細胞は誘導、毒性、薬物代謝などのアッセイにご使用いただけます。ヒト肝臓細胞は、臓器移植に適さないドナー組織から得られた肝臓組織全体より分離されたものです。

細胞は、HIV-1、HIV-2、HbsAG、HbcAB、HCV、およびRPRについて陰性であることを確認済みです。また、CMVもテストされており、一部のCMV陽性のロットは、実験用として提供されます。

*最新のドナー情報については、お問い合わせください。

図1. ヒト肝細胞

【注意事項】
Zen-Bio社の細胞は、推奨の培地および、試薬を用いて、推奨プロトコルに従い培養された場合のみ品質を保証しております。

« Zen-Bio社ヒト初代培養細胞 TOPへ

ヒト肝細胞

品名	メーカー	品番	包装	希望販売価格
Cryopreserved Plateable Hepatocytes, Human	ZEN	HP-F	1 VIAL	お問い合わせ

ヒト肝細胞推奨培地

品名	メーカー	品番	包装	希望販売価格
Hepatocyte Plating Medium	ZEN	HM-1	500 ML	￥125,000
Hepatocyte Plating Medium	ZEN	HM-1-250	250 ML	￥66,000
Hepatocyte Maintenance Medium	ZEN	HM-2	500 ML	￥125,000
Hepatocyte Maintenance Medium	ZEN	HM-2-250	250 ML	￥66,000

ヒト肝非実質細胞

品名	メーカー	品番	包装	希望販売価格
Cryopreserved Hepatic Stellate Cells, Human	ZEN	HP-F-S	1 VIAL [1 x 10^5 cells/vial]	￥192,000
Cryopreserved Kupffer Cells, Human	ZEN	HP-KC-F	1 VIAL [1 x 10^6 cells/vial]	お問い合わせ
Cryopreserved Hepatic Sinusoidal Endothelial Cells, Human	ZEN	HSEC-F	1 VIAL [5 x 10^5 cells/vial]	お問い合わせ
Cryopreserved Intra-Hepatic Biliary Epithelial Cells, Human	ZEN	IHBEC-F	1 VIAL [5 x 10^5 cells/vial]	お問い合わせ

ヒト肝非実質細胞推奨培地

品名	メーカー	品番	包装	希望販売価格
Hepatic/Pancreatic Stellate Growth Medium	ZEN	HSGM-250	250 ML	￥89,000
Hepatic/Pancreatic Stellate Growth Medium	ZEN	HSGM-500	500 ML	￥133,000
Kupffer Cell Plating Medium, (HUMAN)	ZEN	KC-1	250 ML	￥73,000
Kupffer Cell Maintenance Medium, (HUMAN)	ZEN	KC-2	250 ML	￥73,000
Endothelial Cell Growth Medium	ZEN	ECGM-1	500 ML	￥89,000
Intra-Hepatic Biliary Epithelial Cell Growth Medium	ZEN	IHBEC-1	500 ML	￥96,000

製品使用文献

Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis. Kaftanovskaya EM, Ng HH, Soula M, Rivas B, Myhr C, Ho BA, Cervantes BA, Shupe TD, Devarasetty M, Hu X, Xu X, Patnaik S, Wilson KJ, Barnaeva E, Ferrer M, Southall NT, Marugan JJ, Bishop CE, Agoulnik IU, Agoulnik AI. FASEB J. 33(11):12435-12446 (2019). doi: 10.1096/fj.201901046R. PMID: 31419161
Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse. Wang S, Kim J, Lee C, Oh D, Han J, Kim TJ, Kim SW, Seo YS, Oh SH, Jung Y. Biomaterials. 219:119375 (2019). doi: 10.1016/j.biomaterials.2019.119375. PMID: 31374480
sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. Hall KC, Bernier SG, Jacobson S, Liu G, Zhang PY, Sarno R, Catanzano V, Currie MG, Masferrer JL. Proc Natl Acad Sci U S A. 116(22):11057-11062 (2019). doi: 10.1073/pnas.1821045116. PMID: 31085647
Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cells. Kim MB, Bae M, Hu S, Kang H, Park YK, Lee JY. Biochem Biophys Res Commun. 513(3):657-662 (2019). doi: 10.1016/j.bbrc.2019.04.052. PMID: 30982574
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Woodcock HV, Eley JD, Guillotin D, Platé M, Nanthakumar CB, Martufi M, Peace S, Joberty G, Poeckel D, Good RB, Taylor AR, Zinn N, Redding M, Forty EJ, Hynds RE, Swanton C, Karsdal M, Maher TM, Bergamini G, Marshall RP, Blanchard AD, Mercer PF, Chambers RC. Nat Commun. 10(1):6 (2019). doi: 10.1038/s41467-018-07858-8. PMID: 30602778
Human liver spheroid cultures in microfluidic chip co-cultures and comparative MetID studies. JOHANNA ASSERLIND. CHALMERS UNIVERSITY OF TECHNOLOGY
Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway. Jung TW, Kim HC, Abd El-Aty AM, Jeong JH. J Biol Chem. 293(11):3981-3988 (2018). doi: 10.1074/jbc.RA117.000885. PMID: 29414781
WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. Jung TW, Kang C, Goh J, Chae SI, Kim HC, Lee TJ, Abd El-Aty AM, Jeong JH. J Cell Physiol. 233(8):6077-6087 (2018). doi: 10.1002/jcp.26449. PMID: 29319180
Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance. Sajan MP, Lee MC, Foufelle F, Sajan J, Cleland C, Farese RV. Cell Signal. 43:62-70 (2018). doi: 10.1016/j.cellsig.2017.12.005. PMID: 29269047
Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases. Bansal R, Nakagawa S, Yazdani S, van Baarlen J, Venkatesh A, Koh AP, Song WM, Goossens N, Watanabe H, Beasley MB, Powell CA, Storm G, Kaminski N, van Goor H, Friedman SL, Hoshida Y, Prakash J. Exp Mol Med. 49(11):e396 (2017). doi: 10.1038/emm.2017.213. PMID: 29147013
Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Jung TW, Chung YH, Kim HC, Abd El-Aty AM, Jeong JH. Mol Cell Endocrinol. 470:26-33 (2018). doi: 10.1016/j.mce.2017.10.014. PMID: 29111387
An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells. Koui Y, Kido T, Ito T, Oyama H, Chen SW, Katou Y, Shirahige K, Miyajima A. Stem Cell Reports. 9(2):490-498 (2017). doi: 10.1016/j.stemcr.2017.06.010. PMID: 28757162
Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development. Davidson MD1, Kukla DA, Khetani SR. Integr Biol (Camb). 9(8):662-677(2017). doi: 10.1039/c7ib00027h. PMID: 28702667
Protectin DX suppresses hepatic gluconeogenesis through AMPK-HO-1-mediated inhibition of ER stress. Jung TW, Kim HC, Abd El-Aty AM, Jeong JH. Cell Signal. 34:133-140 (2017). doi: 10.1016/j.cellsig.2017.03.013. PMID: 28342842
In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding. Vogel KR, Ainslie GR, Roullet JB, McConnell A, Gibson KM. Toxicol In Vitro. 40:196-202 (2017). doi: 10.1016/j.tiv.2017.01.013. PMID: 28119166